Disulfiram Reactivates Latent HIV-1 in a Bcl-2-Transduced Primary CD4+ T Cell Model without Inducing Global T Cell Activation

ABSTRACT Highly active antiretroviral therapy (HAART) can reduce plasma HIV-1 levels to below the detection limit. However, due to the latent reservoir in resting CD4+ cells, HAART is not curative. Elimination of this reservoir is critical to curing HIV-1 infection. Agents that reactivate latent HIV-1 through nonspecific T cell activation are toxic. Here we demonstrate in a primary CD4+ T cell model that the FDA-approved drug disulfiram reactivates latent HIV-1 without global T cell activation. The extent to which disulfiram reactivates latent HIV-1 in patient cells is unclear, but the drug alone or in combination may be useful in future eradication strategies.

[1]  C. Van Lint,et al.  HIV Persistence and the Prospect of Long-Term Drug-Free Remissions for HIV-Infected Individuals , 2010, Science.

[2]  Jun O. Liu,et al.  Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation. , 2009, The Journal of clinical investigation.

[3]  J. McCune,et al.  Suberoylanilide Hydroxamic Acid Reactivates HIV from Latently Infected Cells* , 2009, Journal of Biological Chemistry.

[4]  J. Coffin,et al.  Valproic acid without intensified antiviral therapy has limited impact on persistent HIV infection of resting CD4+ T cells , 2008, AIDS.

[5]  Z. Sauna,et al.  Disulfiram, an old drug with new potential therapeutic uses for human cancers and fungal infections. , 2005, Molecular bioSystems.

[6]  D. Hamer,et al.  Molecular characterization, reactivation, and depletion of latent HIV. , 2003, Immunity.

[7]  R. Siliciano,et al.  Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells , 2003, Nature Medicine.

[8]  P. Jatlow,et al.  Disulfiram effects on acute cocaine administration. , 1998, Drug and alcohol dependence.

[9]  M A Nowak,et al.  Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[10]  D. Richman,et al.  Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. , 1997, Science.

[11]  R Brookmeyer,et al.  Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. , 1997, Science.

[12]  R. Siliciano,et al.  Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection , 1997, Nature.

[13]  M. Collu,et al.  Disulfiram and diethyldithiocarbamate intoxication affects the storage and release of striatal dopamine. , 1996, Toxicology and applied pharmacology.

[14]  B. Johansson.  A review of the pharmacokinetics and pharmacodynamics of disulfiram and its metabolites , 1992, Acta psychiatrica Scandinavica. Supplementum.

[15]  M. D. Faiman,et al.  Elimination kinetics of disulfiram in alcoholics after single and repeated doses , 1984, Clinical pharmacology and therapeutics.

[16]  Richard I. H. Wang,et al.  Disulfiram and erythrocyte aldehyde dehydrogenase inhibition , 1983, Clinical pharmacology and therapeutics.